Developer docs
API playgroundTry for free, no card

Search company profiles

nanoComposix

Full company profile

uuid0009h96

Namestring
nanoComposix
Legal namestring
nanoComposix, Inc.
Company typeenum
Private
Founded yearint
2004
Descriptiontext

nanoComposix is a San Diego-based nanotechnology company, founded in 2004, that designs, manufactures, and commercializes engineered inorganic nanoparticles — including gold, silver, silica, magnetic, and platinum compositions — for pharmaceutical, diagnostic, life sciences, and adjacent industrial customers. Its core capability is proprietary colloidal synthesis combined with tangential flow filtration purification, allowing reproducible batch production ranging from research-scale to 2,000 liters at 1 OD and 100 liters at 20 OD, with 37 GMP batches produced and 20 preclinical programs supported to date. The platform has been cited in 4,000+ peer-reviewed publications, indicating broad embedding in third-party research and a meaningful installed base among academic and industrial users.

The business operates a dual model. The first leg is a catalog of off-the-shelf nanoparticles and application-ready diagnostic reagents, including the BioReady line and the AmpliDetect multiplex nucleic acid lateral flow platform, distributed through five regional partners covering North America, the UK, Europe, Japan, and Germany/Austria. The second leg is fee-for-service custom synthesis and CDMO work for nanomedicine, with custom projects starting in the low thousands of dollars and scaling into GMP manufacturing agreements. Quality systems are anchored by ISO 13485:2016 certification, FDA drug establishment registration, and a California Drug Manufacturing License.

In July 2021, nanoComposix was acquired by Fortis Life Sciences, placing it inside a roll-up platform in life sciences tools and CDMO services. Headcount sits in the 11–50 range. The company now participates across diverse verticals including pharma, diagnostics, animal health, energy, engineering, and dermatology, reducing dependence on any single end-market.

Short descriptiontext

nanoComposix is a San Diego-based nanotechnology company, founded in 2004 and now part of Fortis Life Sciences, that manufactures engineered gold, silver, silica, magnetic, and platinum nanoparticles for pharmaceutical, diagnostic, and life sciences customers through catalog sales and custom GMP CDMO services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
engineered nanoparticles, nanomedicine manufacturing, diagnostic assay reagents, custom nanoparticle synthesis, CDMO services
Industry1 code
PRIMARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code2 codes
  • Research and Development in Nanotechnology541713
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Miscellaneous Chemical Products2890
Product category
Engineered Nanomaterials
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model6 records
1Catalog Nanoparticle Products
TypeOne Time License
Description

Sale of standardized nanoparticle products across gold, silver, silica, magnetic, platinum, and other materials. Products are sold at various price points based on material, size, surface chemistry, and concentration. Revenue is transactional, one-time per order.

nanocomposix.com
2Bulk Manufacturing
TypeOne Time License
Description

High-volume nanoparticle manufacturing with tiered bulk discounts for customers requiring larger quantities (hundreds of milliliters to hundreds of liters) for commercial applications such as lateral flow assays, coatings, and sensors.

nanocomposix.com
3CDMO Services
TypeProfessional Services
Description

Contract development and manufacturing organization services for nanomedicine development including feasibility studies, pre-clinical development, GMP manufacturing, and regulatory support. Revenue generated through project-based service contracts and milestone payments.

nanocomposix.com
4Custom Nanoparticle Development
TypeProfessional Services
Description

Custom synthesis and development services organized in tiered packages (NanoFab Mini, QuickStart, Pro) to support feasibility studies, optimization, and scale-up assessment. Customers pay for defined development scopes.

5Characterization Services
TypeProfessional Services
Description

Analytical testing services including DLS, ICP-MS, TEM, SEM, UV-Vis, zeta potential, and endotoxin testing offered as standalone services to support customer R&D and quality control needs.

nanocomposix.com
6Custom Conjugation Services
TypeProfessional Services
Description

Custom conjugate development and manufacturing services transforming nanoparticles into application-ready reagents through antibody functionalization, process optimization, and scalable manufacturing.

nanocomposix.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels7 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Pricing details10 tiers
1Gold Nanoparticle Pricing (catalog, small volume)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Gold nanospheres range from $95-$495 depending on size and surface chemistry. 5 nm from $130, 10 nm from $170, 20 nm from $95, 40 nm varies by surface, 80 nm for conjugation from unspecified, 100 nm from $140, gold nanoshells from $175-$205, gold nanorods from $235-$245, ultra uniform gold nanoparticle standard at $495.

nanocomposix.com
2Silver Nanoparticle Pricing (catalog, small volume)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Silver nanospheres from $145 (10 nm) to higher prices for larger sizes. Silver nanocubes from $465 (55 nm) to $ unspecified for 100 nm cubes. Silver shelled gold nanospheres from $345.

nanocomposix.com
3Silica Nanoparticle Pricing (catalog)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Solid silica from $230 (50 nm) to $265 (1 µm). Mesoporous silica from $310-$320 (100 nm). Extra large pore mesoporous silica at $100/mL with 5 mg/mL concentration.

nanocomposix.com
4BioReady Diagnostic Products
ModelUnit PricingBilling cadencePay-as-you-go
Notes

BioReady conjugation kits from $495, streptavidin gold conjugates from $160 (20 nm) to unspecified for 40 nm, NHS dried kit for gold nanoshells from $305, AmpliDetect multiplex NALF from $265.

nanocomposix.com
5Hydroxyapatite Nanoparticles
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$4/mL with minimum order quantity of 50 mL (5 g) for research use materials.

nanocomposix.com
6Titania Nanoparticles
ModelUnit PricingBilling cadencePay-as-you-go
Notes

10 nm titania at $15/mL (minimum 10 mL/100 mg), 250 nm titania at $39/mL (minimum 5 mL/50 mg).

nanocomposix.com
7Custom Development Packages
ModelOtherBilling cadenceMulti-year contract
Notes

NanoFab Mini starting at $6,000 for variations on catalog products; NanoFab QuickStart starting at $15,000 for feasibility and optimization; NanoFab Pro starting at $40,000 for scalability assessment and manufacturing readiness.

8Nanomedicine CDMO Services
ModelOtherBilling cadenceMulti-year contract
Notes

Project-based pricing based on development stage, material requirements, regulatory needs, and scale. Supports preclinical through GMP clinical trial material production.

nanocomposix.com
9Characterization Services
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Colloidal gold characterization at $500; Endotoxin testing from $325; ICP-MS metal analysis from $395; Zeta potential analysis from $285; DLS, SEM, TEM, UV-Vis priced individually.

nanocomposix.com
10Bulk Nanoparticle Pricing (tiered)
ModelUnit PricingBilling cadenceMulti-year contract
Notes

Example 40 nm streptavidin gold: 200 µL at $75/mL, 1 mL at $47.50, 5 mL at $38.10, 10 mL at $32.15, bulk requires contact. 50 nm silver: 100 mL at $95/mg, 500 mL at $72/mg, 1 L at $60/mg. 50 nm silica: 100 mL at $0.76/mg, 500 mL at $0.69/mg, 1 L at $0.60/mg.

nanocomposix.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1BioReady
Description

Product line of nanoparticles optimized for diagnostic assay development, including gold nanoparticles and magnetic beads with conjugation-ready surfaces.

nanocomposix.com
+4 more records
Core offering1 text field

nanoComposix designs, manufactures, and sells precisely engineered nanoparticles — including gold, silver, silica, magnetic iron oxide, platinum, aluminum, hydroxyapatite, titania, and PLGA polymer particles — produced via proprietary colloidal synthesis methods with tight size and shape distributions and a broad surface chemistry platform. The company complements its catalog nanoparticle business with custom synthesis (NanoFab packages), custom conjugation services, contract CDMO services for nanomedicine from feasibility through GMP clinical manufacturing, bulk manufacturing, and analytical characterization services. These products and services support diagnostics developers, pharmaceutical/biotech researchers, optical engineering teams, dermatology and aesthetics customers, and life science researchers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 40 nm streptavidin gold conjugate produces less than 20% signal compared to nanoComposix conjugate at 1 nM analyte concentration in lateral flow comparison testing
+2 more records
Product overview1 text field

nanoComposix is a nanomaterials company that offers a comprehensive portfolio of precisely engineered nanoparticles and contract development manufacturing services. The core product lines include gold nanoparticles (NanoXact, BioReady, Ultra Uniform sub-brands), silver nanoparticles, silica nanoparticles, magnetic iron oxide particles, platinum nanoparticles, and custom nanomaterials (aluminum, hydroxyapatite, titania, PLGA polymers). These are complemented by BioReady diagnostics reagents including conjugation kits and AmpliDetect multiplex detection products. The company provides services including custom nanoparticle development (NanoFab packages), custom conjugation services, Nanomedicine CDMO services, bulk manufacturing, and characterization services. Supporting tools include Mie Theory, conversion, and molecular weight calculators plus an LFA particle selection guide. The portfolio is delivered as a unified offering combining catalog products with development services, enabling customers to progress from research through clinical manufacturing.

Product and service1 record
1Gold Nanoparticles (NanoXact / BioReady / Ultra Uniform)
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierPrimaryTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-03-08
Description

Distribution agreement signed to broaden distribution of nanoComposix products to customers throughout Germany and Austria. nanoComposix products made available through BIOZOL's established distribution network in these markets.

Strategic tierSecondaryTypeStrategic or Co-development PartnerAnnounced on2020-11-17
Description

Joint webinar collaboration featuring Dr. Bischof and Dr. Kholsa from University of Minnesota discussing advancement in nanowarming and impact on critical animal models for drug therapies and genetic studies.

3FluroTech Ltd.
Strategic tierSecondaryTypeStrategic or Co-development PartnerAnnounced on2020-11-12
Description

Joint venture announced for SARS-CoV2 test method optimization. nanoComposix began optimization work on FluroTech's rapid SARS-CoV2 testing technology combining nanoComposix nanoparticle expertise with FluroTech's testing platform.

nanocomposix.com
Strategic tierSecondaryTypeStrategic or Co-development PartnerAnnounced on2020-10-21
Description

Engagement with Therma Bright and Orpheus Medica to accelerate development of CoviSafe rapid saliva test following successful completion of feasibility studies.

Strategic tierPrimaryTypeChannel Partner/ Reseller/ DistributorAnnounced on2019-12-12
Description

Distribution agreement signed to broaden distribution of nanoComposix products to customers throughout Japan.

Strategic tierPrimaryTypeChannel Partner/ Reseller/ DistributorAnnounced on2019-06-07
Description

Partnership established to improve access for customers in Japan to nanoComposix nanoparticle products and technologies.

Strategic tierPrimaryTypeChannel Partner/ Reseller/ DistributorAnnounced on2019-02-28
Description

Partnership established for expanding distribution of nanoComposix materials and technologies to customers throughout Europe.

Strategic tierPrimaryTypeChannel Partner/ Reseller/ DistributorAnnounced on2016-12-13
Description

Distribution agreement signed for distribution of nanoComposix products in the United Kingdom market.

Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

Collaboration on nanoparticle formulation development partnership. Customer reported positive experience with nanoComposix scientists working alongside their team to hone early stage product design.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

BBI Solutions (now part of Sona Nanotech) supplies colloidal gold nanoparticles and conjugation services for diagnostic test manufacturers globally, overlapping nanoComposix's BioReady reagent and lateral-flow assay focus.

TypeDirect peer
Description

Nanopartz manufactures precisely engineered gold and silver nanoparticles with tight size distributions for research, diagnostics, and therapeutic applications — directly overlapping nanoComposix's NanoXact and BioReady product portfolios.

TypeBroad incumbent
Description

Catalent is a top-tier global CDMO with broad drug-product and biologics manufacturing services including biologic and cell-therapy capabilities adjacent to nanomedicine, competing with nanoComposix for outsourced pharmaceutical manufacturing budgets.

TypeDirect peer
Description

Creative Diagnostics offers gold nanoparticle conjugates, lateral-flow components, and diagnostic reagent kits for immunoassay developers, with overlapping product offerings in the diagnostics segment.

TypeDirect peer
Description

Ted Pella manufactures and distributes nanoparticle products and supplies for electron microscopy and life-science research, with gold nanoparticle offerings that overlap nanoComposix's NanoXact catalog.

TypeDirect peer
Description

Nanocs produces functionalized gold, silver, and magnetic nanoparticles plus diagnostic-grade reagents, serving life-science and diagnostic customers in a comparable catalog-plus-custom model.

7MilliporeSigma (Sigma-Aldrich)
TypeBroad incumbent
Description

MilliporeSigma distributes catalog gold, silver, magnetic, and other nanoparticles through a global life-science catalog with very different scale, overlapping nanoComposix's catalog offerings as a much larger incumbent.

TypeDirect peer
Description

Cytodiagnostics offers gold nanoparticle conjugates, conjugation kits, and lateral-flow reagents for diagnostics and biosensors — directly comparable to nanoComposix's BioReady diagnostic reagent line.

9Lubrizol Life Science (Particle Sciences)
TypeDirect peer
Description

Particle Sciences, part of Lubrizol Life Science, is a CDMO specializing in particle-based drug delivery including nanoparticles, PLGA microparticles, and complex formulations — closely matching nanoComposix's nanomedicine CDMO service line.

TypeOthers
Description

Fortis Life Sciences is nanoComposix's parent company (acquired July 2021) and a broader life-sciences platform providing strategic backing, complementary portfolio assets, and cross-portfolio commercial leverage rather than competing directly.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

nanoComposix

Engineered Nanomaterialsnanocomposix.com

nanoComposix is a San Diego-based nanotechnology company, founded in 2004 and now part of Fortis Life Sciences, that manufactures engineered gold, silver, silica, magnetic, and platinum nanoparticles for pharmaceutical, diagnostic, and life sciences customers through catalog sales and custom GMP CDMO services.

What nanoComposix does

nanoComposix is a San Diego-based nanotechnology company, founded in 2004, that designs, manufactures, and commercializes engineered inorganic nanoparticles — including gold, silver, silica, magnetic, and platinum compositions — for pharmaceutical, diagnostic, life sciences, and adjacent industrial customers. Its core capability is proprietary colloidal synthesis combined with tangential flow filtration purification, allowing reproducible batch production ranging from research-scale to 2,000 liters at 1 OD and 100 liters at 20 OD, with 37 GMP batches produced and 20 preclinical programs supported to date. The platform has been cited in 4,000+ peer-reviewed publications, indicating broad embedding in third-party research and a meaningful installed base among academic and industrial users.

The business operates a dual model. The first leg is a catalog of off-the-shelf nanoparticles and application-ready diagnostic reagents, including the BioReady line and the AmpliDetect multiplex nucleic acid lateral flow platform, distributed through five regional partners covering North America, the UK, Europe, Japan, and Germany/Austria. The second leg is fee-for-service custom synthesis and CDMO work for nanomedicine, with custom projects starting in the low thousands of dollars and scaling into GMP manufacturing agreements. Quality systems are anchored by ISO 13485:2016 certification, FDA drug establishment registration, and a California Drug Manufacturing License.

In July 2021, nanoComposix was acquired by Fortis Life Sciences, placing it inside a roll-up platform in life sciences tools and CDMO services. Headcount sits in the 11–50 range. The company now participates across diverse verticals including pharma, diagnostics, animal health, energy, engineering, and dermatology, reducing dependence on any single end-market.

nanoComposix firmographics

Firmographics
Name
nanoComposix
Legal name
nanoComposix, Inc.
Website
https://nanocomposix.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
11–50 employees
Short description
nanoComposix is a San Diego-based nanotechnology company, founded in 2004 and now part of Fortis Life Sciences, that manufactures engineered gold, silver, silica, magnetic, and platinum nanoparticles for pharmaceutical, diagnostic, and life sciences customers through catalog sales and custom GMP CDMO services.
Ownership category
akta.pro rank

nanoComposix industry classification

Industry
Product category
Engineered Nanomaterials
NAICS
Research and Development in Nanotechnology (541713), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731), Miscellaneous Chemical Products (2890)
akta.pro industry
PRIMARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Engineered nanoparticles
  • Nanomedicine manufacturing
  • Diagnostic assay reagents
  • Custom nanoparticle synthesis
  • CDMO services

Where nanoComposix is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices1 record

Markets served

nanoComposix business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Catalog Nanoparticle Products: Sale of standardized nanoparticle products across gold, silver, silica, magnetic, platinum, and other materials. Products are sold at various price points based on material, size, surface chemistry, and concentration. Revenue is transactional, one-time per order.
  2. Bulk Manufacturing: High-volume nanoparticle manufacturing with tiered bulk discounts for customers requiring larger quantities (hundreds of milliliters to hundreds of liters) for commercial applications such as lateral flow assays, coatings, and sensors.
  3. CDMO Services: Contract development and manufacturing organization services for nanomedicine development including feasibility studies, pre-clinical development, GMP manufacturing, and regulatory support. Revenue generated through project-based service contracts and milestone payments.
  4. Custom Nanoparticle Development: Custom synthesis and development services organized in tiered packages (NanoFab Mini, QuickStart, Pro) to support feasibility studies, optimization, and scale-up assessment. Customers pay for defined development scopes.
  5. Characterization Services: Analytical testing services including DLS, ICP-MS, TEM, SEM, UV-Vis, zeta potential, and endotoxin testing offered as standalone services to support customer R&D and quality control needs.
  6. Custom Conjugation Services: Custom conjugate development and manufacturing services transforming nanoparticles into application-ready reagents through antibody functionalization, process optimization, and scalable manufacturing.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goGold Nanoparticle Pricing (catalog, small volume)
Unit PricingPay-as-you-goSilver Nanoparticle Pricing (catalog, small volume)
Unit PricingPay-as-you-goSilica Nanoparticle Pricing (catalog)
Unit PricingPay-as-you-goBioReady Diagnostic Products
Unit PricingPay-as-you-goHydroxyapatite Nanoparticles
Unit PricingPay-as-you-goTitania Nanoparticles
OtherMulti-year contractCustom Development Packages
OtherMulti-year contractNanomedicine CDMO Services
Unit PricingPay-as-you-goCharacterization Services
Unit PricingMulti-year contractBulk Nanoparticle Pricing (tiered)

Go-to-market motion3 records

Distribution channels7 records

Marketing channels9 records

nanoComposix product offering

Product offering

Core offering

nanoComposix designs, manufactures, and sells precisely engineered nanoparticles — including gold, silver, silica, magnetic iron oxide, platinum, aluminum, hydroxyapatite, titania, and PLGA polymer particles — produced via proprietary colloidal synthesis methods with tight size and shape distributions and a broad surface chemistry platform. The company complements its catalog nanoparticle business with custom synthesis (NanoFab packages), custom conjugation services, contract CDMO services for nanomedicine from feasibility through GMP clinical manufacturing, bulk manufacturing, and analytical characterization services. These products and services support diagnostics developers, pharmaceutical/biotech researchers, optical engineering teams, dermatology and aesthetics customers, and life science researchers.

Product overview

nanoComposix is a nanomaterials company that offers a comprehensive portfolio of precisely engineered nanoparticles and contract development manufacturing services. The core product lines include gold nanoparticles (NanoXact, BioReady, Ultra Uniform sub-brands), silver nanoparticles, silica nanoparticles, magnetic iron oxide particles, platinum nanoparticles, and custom nanomaterials (aluminum, hydroxyapatite, titania, PLGA polymers). These are complemented by BioReady diagnostics reagents including conjugation kits and AmpliDetect multiplex detection products. The company provides services including custom nanoparticle development (NanoFab packages), custom conjugation services, Nanomedicine CDMO services, bulk manufacturing, and characterization services. Supporting tools include Mie Theory, conversion, and molecular weight calculators plus an LFA particle selection guide. The portfolio is delivered as a unified offering combining catalog products with development services, enabling customers to progress from research through clinical manufacturing.

Differentiator

Problem solved

Functional benefit

Brands

  • BioReady: Product line of nanoparticles optimized for diagnostic assay development, including gold nanoparticles and magnetic beads with conjugation-ready surfaces.
  • NanoXact
  • BioPure
  • Ultra Uniform
  • NanoFab

Products and services

  • Gold Nanoparticles (NanoXact / BioReady / Ultra Uniform)

Quantifiable outcome

  • 40 nm streptavidin gold conjugate produces less than 20% signal compared to nanoComposix conjugate at 1 nM analyte concentration in lateral flow comparison testing
  • +2 more outcomes

Companies that use nanoComposix

Customer profile

Named customers10 records

Segments5 records

Ideal customer profiles5 records

nanoComposix technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

nanoComposix partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered primary and secondary.

  • BIOZOL Diagnostica Vertrieb GmbHprimaryChannel Partner/ Reseller/ Distributor · 8 March 2021Distribution agreement signed to broaden distribution of nanoComposix products to customers throughout Germany and Austria. nanoComposix products made available through BIOZOL's established distribution network in these markets.
  • University of MinnesotasecondaryStrategic or Co-development Partner · 17 November 2020Joint webinar collaboration featuring Dr. Bischof and Dr. Kholsa from University of Minnesota discussing advancement in nanowarming and impact on critical animal models for drug therapies and genetic studies.
  • FluroTech Ltd.secondaryStrategic or Co-development Partner · 12 November 2020Joint venture announced for SARS-CoV2 test method optimization. nanoComposix began optimization work on FluroTech's rapid SARS-CoV2 testing technology combining nanoComposix nanoparticle expertise with FluroTech's testing platform.
  • Therma Bright Inc.secondaryStrategic or Co-development Partner · 21 October 2020Engagement with Therma Bright and Orpheus Medica to accelerate development of CoviSafe rapid saliva test following successful completion of feasibility studies.
  • EM JapanprimaryChannel Partner/ Reseller/ Distributor · 12 December 2019Distribution agreement signed to broaden distribution of nanoComposix products to customers throughout Japan.
  • VeritasprimaryChannel Partner/ Reseller/ Distributor · 7 June 2019Partnership established to improve access for customers in Japan to nanoComposix nanoparticle products and technologies.
  • CliniSciencesprimaryChannel Partner/ Reseller/ Distributor · 28 February 2019Partnership established for expanding distribution of nanoComposix materials and technologies to customers throughout Europe.
  • Stratech Scientific Ltd.primaryChannel Partner/ Reseller/ Distributor · 13 December 2016Distribution agreement signed for distribution of nanoComposix products in the United Kingdom market.
  • EnduRx Pharmaceuticals Inc.secondaryStrategic or Co-development PartnerCollaboration on nanoparticle formulation development partnership. Customer reported positive experience with nanoComposix scientists working alongside their team to hone early stage product design.

Scale indicators9 records

Recent moves8 records

Expansion highlights6 records

nanoComposix competitors and assessment

Company assessment

Direct peers

  • BBI Solutions: BBI Solutions (now part of Sona Nanotech) supplies colloidal gold nanoparticles and conjugation services for diagnostic test manufacturers globally, overlapping nanoComposix's BioReady reagent and lateral-flow assay focus.
  • Nanopartz: Nanopartz manufactures precisely engineered gold and silver nanoparticles with tight size distributions for research, diagnostics, and therapeutic applications — directly overlapping nanoComposix's NanoXact and BioReady product portfolios.
  • Creative Diagnostics: Creative Diagnostics offers gold nanoparticle conjugates, lateral-flow components, and diagnostic reagent kits for immunoassay developers, with overlapping product offerings in the diagnostics segment.
  • Ted Pella: Ted Pella manufactures and distributes nanoparticle products and supplies for electron microscopy and life-science research, with gold nanoparticle offerings that overlap nanoComposix's NanoXact catalog.
  • Nanocs: Nanocs produces functionalized gold, silver, and magnetic nanoparticles plus diagnostic-grade reagents, serving life-science and diagnostic customers in a comparable catalog-plus-custom model.
  • Cytodiagnostics: Cytodiagnostics offers gold nanoparticle conjugates, conjugation kits, and lateral-flow reagents for diagnostics and biosensors — directly comparable to nanoComposix's BioReady diagnostic reagent line.
  • Lubrizol Life Science (Particle Sciences): Particle Sciences, part of Lubrizol Life Science, is a CDMO specializing in particle-based drug delivery including nanoparticles, PLGA microparticles, and complex formulations — closely matching nanoComposix's nanomedicine CDMO service line.

Broad incumbents

  • Catalent: Catalent is a top-tier global CDMO with broad drug-product and biologics manufacturing services including biologic and cell-therapy capabilities adjacent to nanomedicine, competing with nanoComposix for outsourced pharmaceutical manufacturing budgets.
  • MilliporeSigma (Sigma-Aldrich): MilliporeSigma distributes catalog gold, silver, magnetic, and other nanoparticles through a global life-science catalog with very different scale, overlapping nanoComposix's catalog offerings as a much larger incumbent.

Others

  • Fortis Life Sciences: Fortis Life Sciences is nanoComposix's parent company (acquired July 2021) and a broader life-sciences platform providing strategic backing, complementary portfolio assets, and cross-portfolio commercial leverage rather than competing directly.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

nanoComposix social profiles

Digital presence

nanoComposix compliance and trust

Trust signal

Compliance3 records

nanoComposix financial estimates

Financial estimate

Revenue estimate

Valuation estimate

nanoComposix leadership team

Management profile

Number of profiles

Profiles1 record

nanoComposix funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

nanoComposix M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about nanoComposix

What does nanoComposix do?

nanoComposix designs, manufactures, and sells precisely engineered nanoparticles — including gold, silver, silica, magnetic iron oxide, platinum, aluminum, hydroxyapatite, titania, and PLGA polymer particles — produced via proprietary colloidal synthesis methods with tight size and shape distributions and a broad surface chemistry platform. The company complements its catalog nanoparticle business with custom synthesis (NanoFab packages), custom conjugation services, contract CDMO services for nanomedicine from feasibility through GMP clinical manufacturing, bulk manufacturing, and analytical characterization services. These products and services support diagnostics developers, pharmaceutical/biotech researchers, optical engineering teams, dermatology and aesthetics customers, and life science researchers.

Is nanoComposix a public or private company?

nanoComposix is a private company. It is classified as corporate owned and is currently operating.

When was nanoComposix founded?

nanoComposix was founded in 2004. It employs 11 to 50 people.

Where is nanoComposix based?

nanoComposix is headquartered in San Diego, United States, in the North America region.

How does nanoComposix make money?

Six revenue lines are on record. Catalog Nanoparticle Products are the primary driver. The others are bulk Manufacturing, CDMO Services, custom Nanoparticle Development, characterization Services and custom Conjugation Services.

Who are nanoComposix's main competitors?

Direct peers on record are BBI Solutions, Nanopartz, Creative Diagnostics, Ted Pella, Nanocs, Cytodiagnostics and Lubrizol Life Science (Particle Sciences). Broad incumbents are Catalent and MilliporeSigma (Sigma-Aldrich). Fortis Life Sciences is listed as an others.

Does nanoComposix have an API?

No public API is recorded for nanoComposix.

What industry is nanoComposix in?

nanoComposix's product category is Engineered Nanomaterials. Its primary akta.pro industry code is HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO. Its NAICS code is 541713 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AInvestImagion Restarted Its Cancer-Imaging Supply Chain. The Invoice Goes to Shareholders.Imagion Biosystems resumed MagSense nanoparticle production via a contract with nanoComposix, avoiding in-house manufacturing costs. The company raised AU$3.75 million in June, which covers only two to three quarters of operations. Shareholders repeatedly approve dilutive financings to fund its Phase 1b/2 trial.BioSpaceImagion Resumes MagSense® Nanoparticle Manufacturing CapabilitiesImagion Biosystems will resume MagSense nanoparticle manufacturing with CDMO nanoComposix ahead of its Phase 1b/2 clinical trial. The trial, cleared by the FDA, aims to confirm safety and evaluate efficacy in HER2+ breast cancer patients. The company previously partnered with nanoComposix for Phase 1 material.GurufocusImagion Resumes MagSense® Nanoparticle Manufacturing CapabilitieImagion Biosystems will resume MagSense nanoparticle manufacturing with CDMO nanoComposix ahead of its Phase 1b/2 clinical trial. The trial, cleared by the FDA, aims to confirm safety and evaluate efficacy in detecting nodal metastases in HER2+ breast cancer. The company previously partnered with nanoComposix for Phase 1 production.YahooImagion Resumes MagSense® Nanoparticle Manufacturing CapabilitiesImagion Biosystems announced it will resume MagSense nanoparticle manufacturing with CDMO nanoComposix ahead of its Phase 1b/2 clinical trial. The trial, cleared by the FDA, aims to confirm safety and evaluate efficacy in detecting nodal metastases in HER2+ breast cancer. The company previously partnered with nanoComposix for Phase 1 production.Business Wire BlogImagion Resumes MagSense® Nanoparticle Manufacturing CapabilitiesImagion Biosystems announced it will resume MagSense nanoparticle manufacturing with CDMO nanoComposix ahead of its Phase 1b/2 clinical trial. The trial, cleared by the FDA, aims to confirm safety and evaluate efficacy in detecting nodal metastases in HER2+ breast cancer. The company previously partnered with nanoComposix for Phase 1 production.openPR.comNano Silica Market is expected to Hit US$ 3.64 Billion by 2033 | Emerging key players - nanoComposix, Nanostructured & Amorphous Materials, Inc., EPRUI Biotech Co., Ltd, Astrra ChemicalsDataM Intelligence released a market research report projecting the global nano silica market to grow from US$ 1.15 billion in 2025 to US$ 3.64 billion by 2033, representing a compound annual growth rate of 15.6% during the forecast period. Nano silica, consisting of silicon dioxide particles sized 1-100 nanometers, is primarily used as a reinforcing agent in rubber and plastics, an additive in concrete for strength and durability, and in coatings, adhesives, pharmaceuticals, and electronics. The report identifies key market players including Evonik Industries, Cabot Corporation, NanoPore Incorporated, Wacker Chemical AG, and Dow Corning Corporation, with North America currently leading the market while Asia-Pacific emerges as the fastest-growing region.YouTubePrecision at Scale – Enabling Novel Therapeutics with Nanoparticle ManufacturingThe article serves as a promotional overview for nanoComposix, highlighting its capabilities in manufacturing nanoparticle-based therapeutics from early research and development through to commercial stages. It directs readers to the company's website for detailed information regarding their contract development and manufacturing organization (CDMO) services.News-MedicalOvercoming challenges in Point of Care diagnostics in veterinary medicinenanoComposix scientist Naomi Urbina discusses point-of-care diagnostics in veterinary medicine, noting challenges like test quality evaluation and robustness in field conditions. The company offers assay development, verification, and stability testing to help vets overcome these hurdles.News-MedicalLateral flow assays: The possibilities beyond COVID-19Andre Alfaro of nanoComposix (Fortis Life Sciences) explains lateral flow assays as rapid, low-cost diagnostics, noting their expansion beyond COVID testing. He highlights potential uses in veterinary care, neuroscience, and cancer surveillance, while noting challenges in developing custom platforms and regulatory hurdles for cancer tests.PR NewswirenanoComposix completes ISO13485:2016 Certification for Quality Management SystemnanoComposix, a San Diego-based manufacturer of engineered nanoparticles, has achieved ISO 13485:2016 certification for its Quality Management System, covering the design, development, and manufacturing of nanomaterials for medical device applications. The certification was issued by Perry Johnson Registrars, an accredited ISO registrar, and demonstrates compliance with internationally recognized standards for medical device quality management systems. The company stated the certification will build customer confidence and potentially create new opportunities and collaborations in the medical device sector.